Induction of CYP2D6 Expression during Pregnancy Is Associated with an Increased Activity of Hepatocyte Nuclear Factor 4α

被引:0
|
作者
Pan, Xian [1 ]
Koh, Kwihye [2 ]
Yu, Ai-Ming [3 ]
Jeong, Hyunyoung [1 ,2 ]
机构
[1] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL USA
[2] Univ Illinois, Dept Pharm Practice, Chicago, IL USA
[3] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA
来源
FASEB JOURNAL | 2013年 / 27卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1102.3
引用
收藏
页数:1
相关论文
共 50 条
  • [21] The influence of clomipramine on CYP2D6 activity
    Szewczuk-Boguslawska, Monika
    Kiejna, Andrzej
    Grzesiak, Magdalena
    Beszlej, Jan Aleksander
    Chlebowska, Iwona
    Orzechowska-Juzwenko, Krystyna
    Milejski, Piotr
    PSYCHIATRIA POLSKA, 2007, 41 (02) : 243 - 249
  • [22] Inhibition of CYP2D6 activity by bupropion
    Kotlyar, M
    Brauer, LH
    Tracy, TS
    Hatsukami, DK
    Harris, J
    Bronars, CA
    Adson, DE
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (03) : 226 - 229
  • [23] Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3,*4, and*6), and the metabolic capacity of CYP2D6 in Northern Iranian Population (Mazandaran)
    Shiran, Mohammad R.
    Soteh, Mohammad B. Hashemi
    Merat, Fatemeh
    Sarzare, Fatemeh
    Salehifar, Ebrahim
    DRUG METABOLISM REVIEWS, 2010, 42 : 260 - 261
  • [24] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation:: a study of mutations CYP2D6*3 and CYP2D6*4
    Monek, O
    Paintaud, G
    Bechtel, Y
    Miguet, JP
    Mantion, G
    Bechtel, PR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (01) : 47 - 52
  • [25] Influence of donor and recipient genotypes on CYP2D6 phenotype after liver transplantation: a study of mutations CYP2D6*3 and CYP2D6*4
    O. Monek
    G. Paintaud
    Y. Bechtel
    J. P. Miguet
    G. Mantion
    P. R. Bechtel
    European Journal of Clinical Pharmacology, 1998, 54 : 47 - 52
  • [26] Reduced CYP2D6 activity is a negative risk factor for methamphetamine dependence
    Otani, Kyohei
    Ujike, Hiroshi
    Sakai, Ayumu
    Okahisa, Yuko
    Kotaka, Tatsuya
    Inada, Toshiya
    Harano, Mutsuo
    Komiyama, Tokutaro
    Hori, Toru
    Yamada, Mitsuhiko
    Sekine, Yoshimoto
    Iwata, Nakao
    Iyo, Masaomi
    Sora, Ichiro
    Ozaki, Norio
    Kuroda, Shigetoshi
    NEUROSCIENCE LETTERS, 2008, 434 (01) : 88 - 92
  • [27] ROLE OF KRUPPEL-LIKE FACTOR 9 (KLF9) IN CYTOCHROME P450 2D6 (CYP2D6) INDUCTION DURING PREGNANCY
    Koh, Kwi Hye
    Pan, Xian
    Yu, Ai-Ming
    Jeong, Hyunyoung
    DRUG METABOLISM REVIEWS, 2014, 45 : 31 - 32
  • [28] THE ROLE OF HEPATOCYTE NUCLEAR FACTOR 3β IN CYP2B6 GENE EXPRESSION
    Li, Linhao
    Heyward, Scott
    Wang, Hongbing
    DRUG METABOLISM REVIEWS, 2015, 47 : 69 - 69
  • [29] EXPERIMENTAL CONDITIONS ROUTINELY USED IN HUMAN HEPATOCYTE STUDIES TO IMPROVE THE IN VITRO INDUCTION OF CYP2D6 AND CYP2C
    Martin, Solenne
    Lopez, Beatrice
    Carteret, Jenifer
    Chesne, Christophe
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S59 - S59
  • [30] Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
    Charoenchokthavee, Wanaporn
    Panomvana, Duangchit
    Sriuranpong, Virote
    Areepium, Nutthada
    BREAST CANCER-TARGETS AND THERAPY, 2016, 8 : 149 - 155